Today: 30 June 2026
Browse Category

NASDAQ:WGRX 24 October 2025 - 19 May 2026

Wellgistics Health Doubles, WGRX Heads Into Key Test

Wellgistics Health Doubles, WGRX Heads Into Key Test

Wellgistics Health fell in premarket trading Tuesday, pulling back after a big jump Monday. Investors looked ahead to the company’s Q1 earnings, but also reacted to a late report, pulled proxy documents and an ongoing strategic review that hasn’t revealed much yet. The Nasdaq-listed stock traded at $0.14 in premarket as of 8:06 a.m. EDT, dropping 21.1% from Monday’s close. The shares had closed the prior session at $0.17, which was up 107.8%. Premarket is before the regular session, and moves can be bigger when volume is light. Regular hours on Nasdaq are 9:30 a.m. to 4 p.m. Eastern.
19 May 2026
·
WGRX Stock Soars on Blockchain Deal as Wellgistics Health Eyes Pharma Disruption

WGRX Stock Soars on Blockchain Deal as Wellgistics Health Eyes Pharma Disruption

Wellgistics Health’s stock price is on a tear after embracing blockchain technology. The tiny healthcare logistics firm saw its shares surge from about $0.40 to the mid-$0.70s overnight on news of a cutting-edge partnership. In after-hours trading late Thursday, WGRX jumped 87.9%, nearly doubling in valuebenzinga.com. The stock is now trading around $0.73–$0.76 in pre-market action Friday morningstockanalysis.com – a dramatic move for a company that just days ago was flirting with all-time lows. This spike came on the heels of positive news: Wellgistics announced it signed a letter of intent with DataVault AI to integrate blockchain “PharmacyChain™” smart-contract technology into its operationsstocktitan.net. Investors reacted euphorically to the deal, betting that blockchain could be a game-changer for the company’s prescription fulfillment platform. Before the announcement, WGRX had closed Thursday’s regular session at $0.40benzinga.com, then exploded to $0.76 after hoursbenzinga.com once the news hit. The frenzy pushed Wellgistics’ market capitalization from roughly $37 million to about $67 million overnight, on trading volumes many times higher than normal.
24 October 2025
··

Stock Market Today

  • Concentrix Q2 EPS Comes In Light, Stock Down Nearly 40% for the Year
    June 29, 2026, 7:00 PM EDT. Concentrix (CNXC) posted Q2 earnings of $2.63 a share, a penny below the Zacks Consensus of $2.64. Revenue was $2.46 billion, a 0.43% miss versus estimates, but up from $2.42 billion last year. Concentrix has only topped earnings estimates once in the past four quarters. Shares have dropped about 39.9% since the start of the year, trailing the S&P 500, which is up 7.4%. CNXC has a Zacks Rank #3 (Hold) as earnings estimate revisions remain uneven. Analysts are looking for $3.18 EPS and $2.54 billion revenue next quarter; full-year revenue is forecast at $11.65 billion. The Business-Services group sits in the top 42% of Zacks sectors. Investors are focused on the company's earnings call for any update on guidance.
Go toTop